Navigation Links
BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
Date:11/19/2013

JERUSALEM, Nov. 19, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, announced today the publication of results showing that BL-8040 (formerly known as BKT-140) enables the efficient mobilization of stem cells from the bone marrow into the peripheral blood, thus facilitating autologous stem cell transplantation in multiple myeloma patients. The research was published in the journal, Clinical Cancer Research.

(Logo:  http://photos.prnewswire.com/prnh/20130730/630769)

High-dose chemotherapy followed by autologous stem cell transplantation has emerged as an established treatment modality for a variety of hematologic malignancies, including multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma. Stem cells are mobilized from the bone marrow using granulocyte colony-stimulating factor (G-CSF), harvested from the peripheral blood by apheresis, and re-infused to the patient after chemotherapy. This type of treatment often replaces the more traditional use of bone marrow transplantation, because the stem cells are easier to collect and the treatment allows for a quicker recovery time and fewer complications.

In patients that do not respond well enough to G-CSF (up to 20% in multiple myeloma), treatment is often augmented by Plerixafor, a drug that inhibits CXCR4, a chemokine receptor that is important in hematopoietic stem cell homing to the bone marrow. However, even after the dual treatment, the mobilization of a sufficient number of stem cells remains a difficult objective in a sizeable proportion of patients.

BL-8040 is a novel, potent and selective inhibitor o
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioLineRx Reports Third Quarter 2013 Financial Results
2. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
3. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
4. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
5. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
6. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
7. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
8. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
9. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
10. BioLineRx to Present at 15th International Celiac Disease Symposium
11. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
(Date:4/24/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ) ... five-year revolving credit facility to $120 million from $50 ... will allow the company to increase borrowings by a ... to securing additional commitments from existing lenders or new ... remains December 18, 2018.   "The amended ...
(Date:4/24/2015)... 24, 2015  Elekta has CE marked the latest ... system , enabling European clinics to deliver a sophisticated ... including advanced 3D planning, IMRT, VMAT and stereotactic planning ... Monaco ® v5.10 provides ... efficiency. Advancements in 3D planning as well as the ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Lannett Expands Revolving Credit Facility To $120 Million 2Elekta CE marks for Monaco v5.10 treatment planning system 2
(Date:4/26/2015)... 2015 In an article published last ... the head-neck biomechanics occurring during the use of handheld electronic ... to determine that use of a tablet increases mechanical demand ... times - more than when the neck is in a ... study, but pointing out the potential hazards of overuse of ...
(Date:4/25/2015)... 26, 2015 Diversified Communications has ... healthcare event. The Integrative Healthcare Symposium Canada, as ... 2015 at the Sheraton Parkway Toronto North in ... one of the most anticipated events of the ... CME program. The event aims to gather multi-disciplined ...
(Date:4/25/2015)... 2015 The federal multidistrict litigation ... filed against C.R. Bard, Inc. continues to move ... of West Virginia. According to a Pretrial Order ... that day, after certain defendants submitted amended responses ... Order directed that any Preliminary Motions referenced during ...
(Date:4/25/2015)... Gardant Management Solutions will lead sessions ... and sales and marketing at the LeadingAge Illinois ... held from April 29 through May 1 in ... eldercare association in Illinois. The statewide association represents ... including senior housing, assisted living and supportive living ...
(Date:4/25/2015)... 2015 For thirteen years, the Twin Cities ... education event in the nation! This year, on May 5th, ... US to take DI Day on the road by supporting ... CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura ... on the change by stating, "The first Twin Cities DI ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2
... (May 14, 2008) SAGE, the worlds fifth ... in medical publishing with the acquisition of the ... Journal of the Renin-Angiotensin-Aldosterone System. , Published six ... & Vascular Disease (BJDVD) explores the relationship between ...
... WASHINGTON, May 19 It,s important to choose,foods wisely in ... Food,and Drug Administration (FDA) offers help. And it,s right on ... has, for many, become a,regular part of shopping. If you ... thing you look for. Calories per serving is,easy to understand. ...
... NEW YORK, May 19 WebMD Health Corp. (Nasdaq:,WBMD) ... that executives,of WebMD are scheduled to participate at the ... 2008 at 11:45 a.m. ET., Investors, analysts and ... audio broadcast of the presentation over the Internet. The ...
... CITY, May 19 The Arena Football,League (AFL) has ... the lives of children at children,s hospitals throughout the ... 9 of the 2008 regular season,as AFL Children,s Miracle ... Network Celebration is to,generate awareness and raise funds for ...
... has long been known that prolonged exposure to the ... deadliest form of skin cancer. An unanswered question, however, ... melanoma than others. Despite years of research and clinical ... According to the National Cancer Institute, the percentage of ...
... herb used in traditional medicine by many Middle Eastern ... one of the most difficult cancers to treat. Researchers ... found that thymoquinone, an extract of nigella sativa seed ... cells by enhancing the process of programmed cell death. ...
Cached Medicine News:Health News:SAGE acquires 2 new medical journals 2Health News:%DV: Adding Up a Balanced Diet 2Health News:Children's Miracle Network and Arena Football League Partner for First Nationwide Celebration Event 2Health News:Researchers close in on new melanoma gene 2Health News:Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report 2
Flattened 13 mm "Graefe type" hook, with 1.5 mm oval hole. Flat serrated handle with polished finish. Overall length: 5.6 inches....
Blunt, fine curved shaft hook to unroll membranes. 24 gauge shaft with dark finish for reduced glare....
0.2 mm Sinskey hook with shaft angled 45 degrees, 10 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches....
Medicine Products: